See more : Primeserv Group Limited (PMV.JO) Income Statement Analysis – Financial Results
Complete financial analysis of Radient Technologies Inc. (RDDTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Radient Technologies Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Zimi Limited (ZMM.AX) Income Statement Analysis – Financial Results
- Janus Corporation Limited (JANUSCORP.BO) Income Statement Analysis – Financial Results
- Cargotec Corporation (CYJBY) Income Statement Analysis – Financial Results
- AGP Corporation (9377.T) Income Statement Analysis – Financial Results
- Liaoning Port Co., Ltd. (601880.SS) Income Statement Analysis – Financial Results
Radient Technologies Inc. (RDDTF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.radientinc.com
About Radient Technologies Inc.
Radient Technologies Inc., together with its subsidiaries, processes, manufactures, sells, and distributes cannabis materials in Canada and internationally. It offers vape cartridges or dabs, cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification, and isolation of cannabinoids for third parties. Its ingredients are used in food and beverage, nutraceuticals, pharmaceuticals, cosmetics, and personal care industries. Radient Technologies Inc. was incorporated in 2001 and is headquartered in Edmonton, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 3.62M | 2.49M | 18.40M | 214.06K | 455.83K | 293.45K | 626.46K | 131.41K | 181.09K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 3.43M | 2.98M | 17.96M | 131.25K | 260.72K | 178.88K | 340.05K | 504.39K | 482.05K | 0.00 | 0.00 |
| Gross Profit | 0.00 | 188.38K | -495.61K | 447.95K | 82.81K | 195.11K | 114.57K | 286.40K | -372.99K | -300.96K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 5.20% | -19.91% | 2.43% | 38.69% | 42.80% | 39.04% | 45.72% | -283.84% | -166.20% | 0.00% | 0.00% |
| Research & Development | 0.00 | 346.31K | 1.06M | 3.97M | 2.72M | 1.06M | 592.64K | 0.00 | 599.83K | 550.67K | 0.00 | 0.00 |
| General & Administrative | 0.00 | 4.74M | 10.15M | 20.06M | 24.12M | 12.22M | 3.12M | 3.07M | 4.53M | 2.96M | 66.69K | 0.00 |
| Selling & Marketing | 0.00 | 271.46K | 185.59K | 1.41M | 1.29M | 656.16K | 230.05K | 194.57K | 313.80K | 337.37K | 0.00 | 0.00 |
| SG&A | 0.00 | 4.74M | 10.15M | 20.06M | 24.12M | 12.22M | 3.12M | 3.26M | 4.84M | 3.29M | 66.69K | 0.00 |
| Other Expenses | 0.00 | 106.51K | -597.28K | 25.04K | 24.33K | 74.37K | 113.85K | 147.97K | -834.51K | 167.59K | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 6.80M | 13.37M | 26.26M | 27.96M | 13.83M | 4.17M | 4.19M | 7.04M | 4.55M | 66.69K | 0.00 |
| Cost & Expenses | 0.00 | 10.23M | 16.35M | 44.22M | 28.10M | 14.09M | 4.35M | 4.53M | 7.54M | 5.03M | 66.69K | 0.00 |
| Interest Income | 0.00 | 323.44K | 446.26K | 230.43K | 444.63K | 66.25K | 22.82K | 19.06K | 9.99K | 107.00 | 4.37K | 0.00 |
| Interest Expense | 0.00 | 1.94M | 2.60M | 834.34K | 445.24K | 196.52K | 185.35K | 144.59K | 366.99K | 1.14M | 79.00 | 0.00 |
| Depreciation & Amortization | 167.90K | 1.71M | 2.16M | 2.23M | 1.13M | 539.89K | 455.83K | 442.99K | 1.07M | 398.06K | 79.00 | 0.00 |
| EBITDA | 0.00 | -5.21M | -12.49M | -23.51M | -26.55M | -13.31M | -3.68M | -3.62M | -7.20M | -4.57M | -3.40M | 0.00 |
| EBITDA Ratio | 0.00% | -143.87% | -501.76% | -127.73% | -12,400.87% | -2,914.15% | -1,260.28% | -577.79% | -5,478.59% | -2,080.08% | 0.00% | 0.00% |
| Operating Income | 0.00 | -6.92M | -14.65M | -25.73M | -27.67M | -7.90M | -4.05M | -3.53M | -6.47M | -4.86M | -66.76K | 0.00 |
| Operating Income Ratio | 0.00% | -191.20% | -588.37% | -139.83% | -12,927.85% | -1,732.56% | -1,381.43% | -563.07% | -4,922.74% | -2,681.44% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | -6.32M | -28.40M | -11.60M | -1.03M | -913.40K | -262.50K | -415.41K | -7.26M | -469.10K | 4.37K | 0.00 |
| Income Before Tax | 0.00 | -12.93M | -42.27M | -37.42M | -27.86M | -14.05M | -4.32M | -4.37M | -14.14M | -5.32M | -62.39K | 0.00 |
| Income Before Tax Ratio | 0.00% | -357.01% | -1,697.84% | -203.31% | -13,012.97% | -3,081.94% | -1,470.89% | -697.04% | -10,758.75% | -2,940.48% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 2.04M | 2.00M | 859.37K | 424.53K | 195.76K | 360.52K | 334.25K | -440.20K | 1.32M | 0.00 | 0.00 |
| Net Income | 0.00 | -12.93M | -42.27M | -37.42M | -27.86M | -14.05M | -4.32M | -4.37M | -14.14M | -5.32M | -62.39K | 0.00 |
| Net Income Ratio | 0.00% | -357.01% | -1,697.84% | -203.31% | -13,012.97% | -3,081.94% | -1,470.89% | -697.04% | -10,758.75% | -2,940.48% | 0.00% | 0.00% |
| EPS | 0.00 | -0.03 | -0.13 | -0.14 | -0.11 | -0.07 | -0.05 | -0.09 | -0.45 | -22.07 | -0.10 | 0.00 |
| EPS Diluted | 0.00 | -0.03 | -0.13 | -0.14 | -0.11 | -0.07 | -0.05 | -0.09 | -0.45 | -22.07 | -0.10 | 0.00 |
| Weighted Avg Shares Out | 530.87M | 452.59M | 325.35M | 272.18M | 251.88M | 188.64M | 85.86M | 49.33M | 31.58M | 241.28K | 600.00K | 810.00K |
| Weighted Avg Shares Out (Dil) | 530.87M | 452.59M | 325.35M | 272.18M | 251.88M | 188.64M | 85.86M | 49.33M | 31.58M | 241.28K | 600.00K | 810.00K |
Radient Technologies Announces partnership with US based Dreamy CBD
Source: https://incomestatements.info
Category: Stock Reports